4.3 Article

ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-κB-dependent activation of Snail

期刊

ONCOTARGET
卷 5, 期 9, 页码 2827-2838

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.1940

关键词

Epithelial-mesenchymal transition; matrix metalloproteinase-3; reactive oxygen species; nuclear factor-kappa B; Snail; breast cancer

资金

  1. NCI [CA122086]
  2. Susan B. Komen foundation [KG110542]
  3. Mayo Clinic Breast Cancer SPORE [CA116201]

向作者/读者索取更多资源

Epithelial-mesenchymal transition (EMT) is characterized by loss of cell-cell junctions, polarity and epithelial markers, and in turn, acquisition of mesenchymal features and motility. Changes associated with this developmental process have been extensively implicated in breast cancer progression and metastasis. Matrix metalloproteinases (MMPs) have been identified as specific inducers of EMT in mammary epithelial cells. MMP-3 induces EMT associated with malignant transformation via a pathway dependent upon production of reactive oxygen species (ROS). While the process by which exposure to MMP-3 leads to induction of ROS has been extensively studied, exactly how the MMP-3-induced ROS stimulate EMT remains unknown. Here, we used profiling methods to identify MMP-3-induced transcriptional alterations in mouse mammary epithelial cells, finding common overlap with changes mediated by nuclear factor-kappa B (NF-kappa B) and found in advanced breast cancer. In cultured cells, we found that Snail, an ROS-dependent key mediator of MMP-3-induced changes, is regulated by NF-kappa B in response to MMP-3. More specifically, we found MMP-3 to cause binding of p65 and cRel NF-kappa B subunits to the Snail promoter, leading to its transcription. Our results identify a specific pathway by which MMPs induce EMT and malignant characteristics, and provide insight into potential therapeutic approaches to target MMP-associated breast cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据